StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
Publishing Date
2023 - 03 - 30
1
2023 - 02 - 21
1
2022 - 09 - 19
1
2022 - 08 - 08
1
2022 - 08 - 04
1
2022 - 05 - 09
1
2022 - 04 - 04
1
2022 - 02 - 28
1
2022 - 01 - 18
1
2022 - 01 - 06
1
2021 - 11 - 10
1
Sector
Consumer non-durables
11
Health technology
9
Manufacturing
11
Tags
Acquire
8
Acquisition
27
Agreement
15
America
13
Biotech-bay
11
Brands
11
Business
12
Cancer
9
Cel
8
Ces
9
Collaboration
7
Commercial
7
Companies
11
Conference
10
Disease
11
Energy
44
Europe
15
Expansion
8
Expected
9
Fashion
13
Fda
8
Financial
30
Global
49
Group
27
Growing
14
Growth
87
Health
10
Insurance
9
International
13
Management
16
Marine
9
Maritime
11
Market
179
N/a
1063
Offering
13
One
8
Partnership
21
Platform
16
Pneumococcal
14
Positive
11
Potential
8
Program
14
Report
53
Research
37
Results
77
Retail
8
Sales
10
Security
8
Services
11
Set
10
Solutions
11
Study
14
Technology
13
Therapeutics
12
Total
12
Trends
10
Trust
10
Update
13
Vax-24
11
Year
17
Entities
Danaher corporation
1
Kering
11
Sutro biopharma, inc.
9
Vaxcyte, inc.
9
Symbols
A
34
ABVC
12
ACET
16
ALGS
16
AMGN
28
ANIX
21
ARAY
13
ASLN
12
ATRA
24
AVGR
14
BBIO
15
BCDA
12
BEAT
14
BGNE
15
BIO
21
BMEA
12
BMY
15
BTCY
18
BTTX
19
CBAY
16
CDNA
27
CHRS
13
CTMX
13
DVAX
19
EIGR
20
EXEL
24
GERN
23
GH
37
GILD
48
HGEN
13
IDYA
24
JAGX
22
JNJ
28
LLY
24
MIRM
49
MS
27
NBY
24
NKTR
16
NRIX
15
NSTG
15
NVRO
17
OM
21
PCVX
15
PLSE
31
PSNL
26
RARE
16
RCUS
15
RIGL
13
RNXT
14
SGMO
20
SMMT
13
SNY
43
SNYNF
32
STRO
16
TWST
53
TXG
13
VCYT
51
VIR
16
VTGN
29
VXRT
16
Exchanges
Nasdaq
11
Nyse
1
Crawled Date
2023 - 03 - 30
1
2023 - 02 - 21
1
2022 - 09 - 19
1
2022 - 08 - 08
1
2022 - 08 - 04
1
2022 - 05 - 09
1
2022 - 04 - 04
1
2022 - 02 - 28
1
2022 - 01 - 18
1
2022 - 01 - 06
1
2021 - 11 - 10
1
Crawled Time
13:00
1
14:00
1
15:00
2
17:00
1
19:00
2
21:00
1
22:00
1
23:00
2
Source
www.biospace.com
11
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Biotech-bay
symbols :
Ppruf
save search
Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants
Published:
2023-03-30
(Crawled : 15:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-42.24%
|
O:
2.52%
H:
2.74%
C:
2.74%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-43.2%
|
O:
1.88%
H:
1.04%
C:
0.57%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
69.42%
|
O:
-0.52%
H:
0.55%
C:
-1.06%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-20.34%
|
O:
-1.05%
H:
2.86%
C:
-5.08%
vax-24
disease
pneumococcal
study
phase 2
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants
Published:
2023-02-21
(Crawled : 14:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-43.3%
|
O:
-3.64%
H:
3.09%
C:
1.33%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-43.19%
|
O:
-1.68%
H:
1.12%
C:
-0.58%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
41.18%
|
O:
-0.93%
H:
1.96%
C:
0.55%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-38.91%
|
O:
-1.13%
H:
5.37%
C:
-0.98%
vax-24
fda
clearance
drug
disease
application
pneumococcal
Chan Zuckerberg Initiative Announces Partnership to Advance Genomics Research at the Nation's Four Historically Black Medical Colleges
Published:
2022-09-19
(Crawled : 19:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-25.8%
|
O:
-0.84%
H:
4.83%
C:
1.27%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-27.37%
|
O:
-1.81%
H:
2.18%
C:
2.09%
partnership
research
genomics
Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update
Published:
2022-08-08
(Crawled : 22:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-33.43%
|
O:
5.95%
H:
0.0%
C:
-1.24%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-35.01%
|
O:
1.46%
H:
0.62%
C:
-0.53%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
140.76%
|
O:
0.62%
H:
0.13%
C:
-0.65%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-34.03%
|
O:
0.69%
H:
10.52%
C:
6.72%
update
results
Vaxcyte Provides Positive Regulatory Updates for VAX-24 Adult and Pediatric Programs
Published:
2022-08-04
(Crawled : 17:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-34.46%
|
O:
0.0%
H:
5.96%
C:
2.52%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-36.0%
|
O:
0.04%
H:
1.21%
C:
0.78%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
154.92%
|
O:
1.43%
H:
3.54%
C:
3.14%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-29.24%
|
O:
1.68%
H:
1.28%
C:
0.55%
vax-24
positive
Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update
Published:
2022-05-09
(Crawled : 21:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-24.45%
|
O:
-0.12%
H:
0.5%
C:
-4.16%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-25.34%
|
O:
-2.22%
H:
0.4%
C:
-1.38%
DHR
|
$235.51
-0.36%
0.0%
2.3M
|
Health Technology
|
-3.55%
|
O:
-1.74%
H:
0.98%
C:
-2.24%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
157.23%
|
O:
-1.4%
H:
2.32%
C:
-10.53%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-33.57%
|
O:
1.05%
H:
1.04%
C:
-12.98%
results
Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults
Published:
2022-04-04
(Crawled : 13:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-42.56%
|
O:
3.35%
H:
0.0%
C:
-3.24%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-43.59%
|
O:
0.03%
H:
1.08%
C:
0.94%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
162.2%
|
O:
-0.8%
H:
10.94%
C:
7.96%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-55.61%
|
O:
0.47%
H:
3.37%
C:
2.67%
vax-24
ongoing
phase 1
phase 2
Vaxcyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published:
2022-02-28
(Crawled : 23:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-49.18%
|
O:
1.35%
H:
0.69%
C:
-2.73%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-50.24%
|
O:
-3.29%
H:
2.78%
C:
0.27%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
176.24%
|
O:
-0.66%
H:
3.83%
C:
3.21%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-57.21%
|
O:
-1.13%
H:
3.08%
C:
1.59%
financial results
report
results
Mahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program
Published:
2022-01-18
(Crawled : 19:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-53.64%
|
O:
-2.63%
H:
1.5%
C:
0.9%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-52.91%
|
O:
-0.22%
H:
0.93%
C:
-0.64%
health
therapeutics
cel
accelerator program
program
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease
Published:
2022-01-06
(Crawled : 15:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-55.66%
|
O:
2.64%
H:
0.0%
C:
-0.39%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-56.36%
|
O:
-0.99%
H:
0.0%
C:
-1.16%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
161.1%
|
O:
4.14%
H:
2.57%
C:
-1.0%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-73.92%
|
O:
-20.18%
H:
0.0%
C:
-9.63%
vax-24
new drug
fda
clearance
application
drug
disease
fda clearance
pneumococcal
Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
Published:
2021-11-10
(Crawled : 23:00)
- biospace.com/
PPRUF
|
$358.55
37.56%
1.5K
|
Consumer Non-Durables
|
-54.68%
|
O:
-1.46%
H:
0.0%
C:
-2.17%
PPRUY
|
$36.0023
-0.11%
220K
|
Manufacturing
|
-54.52%
|
O:
-3.0%
H:
0.18%
C:
-1.12%
PCVX
|
$60.82
0.33%
0.33%
1.3M
|
Health Technology
|
150.62%
|
O:
-0.36%
H:
1.57%
C:
-0.6%
STRO
|
$3.635
-3.58%
-3.71%
520K
|
Health Technology
|
-82.47%
|
O:
0.32%
H:
1.26%
C:
-0.78%
financial results
results
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.